Medical Journals

Acute Vincristine Pretreatment Protects Adult Mouse Cardiac Myocytes from Oxidative Stress.

Authors:
  • Chatterjee Kanu
  • Zhang Jianqing
  • Honbo Norman
  • Simonis Uschi
  • Shaw Robin
  • Karliner Joel S

From: Cardiology Division, University of California, San Francisco, USA.

Journal of molecular and cellular cardiology

  • Publish Date: Sep 2007
  • ISSN: 0022-2828
  • Volume: 43
  • Issue: 3
  • Pages: 327-36
  • Medium: Print
  • Language: English
  • Citation (JAMA): Chatterjee Kanu, Zhang Jianqing, Honbo Norman, et al. Acute Vincristine Pretreatment Protects Adult Mouse Cardiac Myocytes from Oxidative Stress.. J. Mol. Cell. Cardiol. Sep 2007;43:327-36

Abstract

Vincristine is a chemotherapeutic agent that disrupts microtubules. We noted that paclitaxel (Taxol), which stabilizes microtubules, protected cultured adult mouse cardiac myocytes from oxidative stress induced by H(2)O(2). We hypothesized that vincristine, which disrupts microtubules, should have the opposite effect. To our surprise, we found that pretreatment with concentrations of vincristine ranging from 30 to 120 micromol/L for 60 min preserved myocyte viability and morphology after incubation with 30 micromol/L of H(2)O(2) for 35 min as measured by trypan blue exclusion. The cardioprotective effects of vincristine were also observed during prolonged hypoxia. With continuous exposure to vincristine, survival lasted for as long as 24 h, but longer periods of exposure up to 42 h resulted in extensive cell death. Despite microtubule disruption evidenced on deconvolution microscopy, vincristine activated a prosurvival pathway resulting in increased phosphorylation of Akt, ERK and GSK-3beta and in reduced cytochrome C release into the cytosol. Pharmacological inhibitors of Akt and Erk attenuated the cardioprotective effect of vincristine. We conclude that short-term pretreatment with vincristine exerts dramatic protective effects in cultured adult mouse myocytes subjected to acute oxidative stress. Despite causing microtubule disruption, vincristine initiates a prosurvival signaling pathway. As vincristine and doxorubicin are often used in conjunction to treat patients, it is possible that vincristine could be used to modify the cardiotoxicity of doxorubicin.

Mesh Headings (Keywords): Animals, Cardiotonic Agents, Cell Survival, Cells, Cultured, Dose-Response Relationship, Drug, Heart Ventricles, Hydrogen Peroxide, Male, Mice, Mice, Inbred C57BL, Microtubules, Myocytes, Cardiac, Oxidants, Oxidative Stress, Time Factors, Vincristine


Check for Full Text / PubMed Unique Identifier (PMID): 17662302


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.